Topical NSAIDs are associated with a lower risk for cardiovascular events compared with oral NSAIDs in patients with rheumatoid arthritis.
Optimal management of cardiovascular disease (CVD) risk factors continues to be a key objective of CVD risk management in patients with RA.
Predictors of subclinical accelerated atherosclerosis were examined in a recent study of patients with spondyloarthritis without overt cardiovascular disease.
Individuals with new-onset rheumatoid arthritis are at increased risk of acute coronary syndrome.
Researchers from Iran conduct a meta-analysis to determine the prevalence and risk for metabolic syndrome among patients with rheumatoid arthritis.
Study analyzes insurance claims data to examine the relationship between allopurinol use in patients with both gout and diabetes and its effect on cardiovascular event risk.
Study uses data from the Framingham Offspring Cohort to investigate possible relationships between knee osteoarthritis and components of the metabolic syndrome.
An international team of researchers collected data from the Osteoarthritis Initiative to determine the effect of knee osteoarthritis on development of hypertension.
Study uses registry data from Sweden to evaluate heart failure risk before and after diagnosis of rheumatoid arthritis.
Guidelines on recommending statin treatment for African Americans differ between the US Preventive Services Task Force and the American College of Cardiology/American Heart Association.
Analysis finds rapid increase in the risk of non-ischemic heart failure after onset of rheumatoid arthritis.
Consuming adequate amounts of the right nutrients, and limiting others, can help relieve symptoms and improve outcomes in patients with systemic lupus erythematosus.
Study reviewed information from 1.8 million individuals in England admitted to a hospital with an autoimmune disease.
Connecticut considers rheumatoid arthritis and fibromyalgia for medical marijuana treatment, while Lyme disease-carrying deer ticks continue to invade Michigan. All this and more in this week's edition.
Research comes from meta-analysis of 25 population-based studies on 5 major forms of arthritis.
Cohort study of patients with rheumatoid arthritis who newly initiated tocilizumab or tumor necrosis factor inhibitor therapy using multi-database claims data.
Cytomegalovirus Connection With Rheumatoid Arthritis Cardiovascular Disease Risk: An Expert InterviewMarch 01, 2017
Florian Kern, deputy director of research at Brighton and Sussex Medical School in the United Kingdom, discusses his recently published review wherein he and his colleagues make the case that cytomegalovirus is a major driver of cardiovascular disease in patients with rheumatoid arthritis.
Scientists at Imperial College London analyzed 95 studies that included almost 2 million people.
Study evaluated cardiovascular risk in patients with a new diagnosis of gout using risk prediction tools and carotid ultrasound.
Study investigators suggest clinicians consider more aggressive preventive therapy for cardiovascular disease in patients with rheumatoid arthritis who have experienced a fragility fracture.
Study examines relationship between cardiovascular disease risk factors, rotator cuff tendinopathy, and glenohumeral joint pain.
Research shows that younger survivors are at increased risk of serious long-term health conditions resulting from thyroid cancer treatments.
Women with systemic lupus erythematosus and depression were more likely to have increased carotid intima-media thickness compared with those with SLE without depression.
Study examines the effect of TNFi therapy on inflammation and its ability to reduce the incidence of myocardial infarction.
Data show biologics may help with comorbid cardiovascular disease conditions, but more studies are needed regarding their impact on depression, gastrointestinal disease, and osteoporosis.
The prevalence and severity of coronary atherosclerosis, measured by coronary CT angiography, were compared in patients with psoriatic arthritis and age/gender-matched controls.
Patients with cutaneous lupus erythematosus (CLE) were assessed for their risk of cerebrovascular accidents, ischemic heart disease, and peripheral arterial disease.
Study examines whether cardiovascular disease risk algorithms may be more useful if paired with imaging technology in patients with RA.
Glucocorticoid therapy is associated with increased cardiovascular and mortality risk, and it has been proposed that its impact on endothelial function may be to blame. However, a recent review determined that available data regarding this proposed mechanism are mixed.
Retrospective research shows that each year following smoking cessation was linked with reduced risk of death from circulatory disease in former heavy smokers.
Rheumatology Advisor Articles
- Baricitinib Shows Positive Results for Systemic Lupus Erythematosus in Phase 2 Study
- Bimekizumab Linked to 12-Week Clinical Improvements in Ankylosing Spondylitis
- Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis
- Biologic Therapy in Ankylosing Spondylitis: Insights From Social Media
- Sprifermin Improved Cartilage Morphology, Thickness in Knee Osteoarthritis
- Examining the Therapeutic Possibilities of Nutrition in Fibromyalgia
- Managing Cognitive Dysfunction in Systemic Lupus Erythematosus
- Sex-Based Differences in Rheumatoid Arthritis: Clinical Implications and Patient Management
- False-Positive Tuberculin Skin Test Results Linked to Methotrexate Therapy
- Risk of Developing Herpes Zoster Increased in Rheumatoid Arthritis
- Occupational Exposure to Fumes Increases Rheumatoid Factor Levels in RA
- Does Maintenance of Certification Status Affect Patient Care?
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit
- Poverty, Neighborhood May Affect Outcomes in Systemic Lupus Erythematosus
- Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis